KAMATAKI Tetsuya | Institute of Research and Development, Fujimoto Pharmaceutical Corporation
スポンサーリンク
概要
Institute of Research and Development, Fujimoto Pharmaceutical Corporation | 論文
- Contribution of endogenous glycine site NMDA agonists to excitotoxic retinal damage in vivo
- Retinal Neurotoxicity of Nitric Oxide Donors With Different Half-Life of Nitric Oxide Release: Involvement of N-Methyl-D-aspartate Receptor
- Metabolism of Selegiline Hydrochloride, a Selective Monoamine B-type Inhibitor, in Human Liver Microsomes